Institution
The Maria Sklodowska-Curie National Research Institute of Oncology
Also known as: Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie · Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology · Marii Skłodowskiej-Curie Państwowy Instytut Badawczy · Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy · Radium Institute
- 302running trials
- 135closed trials
- 13,414publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland
Recruiting
Not yet recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Recruiting
Recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Recruiting
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Recruiting
Showing 50 of 302.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer37 recruiting
- Colorectal cancer15 recruiting
- Prostate cancer12 recruiting
- Gastric and oesophageal cancer11 recruiting
- Follicular lymphoma9 recruiting
- Liver and biliary tract cancer9 recruiting
- Melanoma9 recruiting
- Metastatic breast cancer9 recruiting
- Multiple myeloma8 recruiting
- Pancreatic cancer8 recruiting
- Childhood cancers7 recruiting
- Hodgkin lymphoma7 recruiting
- Ovarian cancer7 recruiting
- Sarcoma7 recruiting
- Head and neck cancer6 recruiting
- Diffuse large B-cell lymphoma5 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Endometrial cancer4 recruiting
- Kidney cancer4 recruiting
- Triple-negative breast cancer4 recruiting
- Bladder cancer3 recruiting
- Cervical cancer3 recruiting
- Crohn's disease3 recruiting
- Mantle cell lymphoma3 recruiting
- Neuroendocrine tumours3 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Brain metastases1 recruiting
- Heart failure1 recruiting
- Mesothelioma1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Clinical trial of MK-7648A in adults and children with skin cancer
Completed
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Completed
A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer
Completed
Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors
Completed
Active, not recruiting
Completed
Recruiting
Recruiting
Completed
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Active, not recruiting
Active, not recruiting
Completed
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
Completed
Showing 50 of 135.
Registry name variants (20)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
Warsaw, 02-781
412 trials
Maria Sklodowska-Curie - National Research Institute of Oncology
Warsaw, 02-781
7 trials
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy
Warsaw, 02-034
5 trials
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, PL 02 781
4 trials
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw, 02-781
3 trials
NCT03838718REtroperitoneal SArcoma Registry: an International Prospective Initiative
Contact: Piotr Rutkowski, MD
NCT00002462RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
Klinika Nowotworów Piersi i Chirurgii Rekonstrukcyjnej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy
Warsaw, 02-781
1 trial
Maria Skłodowska-Curie National Research Institute of Oncology
Warsaw
1 trial
NCT07850453Vortosiran for VTE Prevention
Contact: Lucjan Wyrwicz, Professor
Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw
Warsaw
1 trial
Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Warsaw, 02-781
1 trial
Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie â€" Panstwowy Instytut Badawczy
Warsaw, 02-781
1 trial
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy - Dept of Lungs and Chest Oncology
Warsaw
1 trial
NCT03815643Avelumab Program Rollover Study
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
Warsaw, 02-781
1 trial
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Onkologii i Radioterapii
Warsaw, Masovian Voivodeship 02-034
1 trial
NCT07623174A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland
Contact: Lucjan Wyrwicz (principal investigator)
The Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, 00-001
1 trial
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie w Warszawie
Warsaw
Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, 02-781
Maria Sklodowska-Curie National Research Institute of Oncology (Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie)
Warsaw
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Klinika Onkologii i Radioterapii
Warsaw, 02-034
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej
Warsaw, Masovian Voivodeship 02-781
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - w Warszawie - Klinika Nowotworow Piersi i Chirurgii Rekonstrukcyjnej
Warsaw, 02-781
Conditions
Diseases this institution publishes on or runs trials for.
- Melanoma86 works · 41 trials
- Sarcoma50 works · 15 trials
- Triple-negative breast cancer38 works · 14 trials
- Head and neck cancer17 works · 13 trials
- Metastatic breast cancer14 works · 33 trials
- Hodgkin lymphoma13 works · 18 trials
- Chronic lymphocytic leukaemia13 works · 9 trials
- Brain metastases13 works · 3 trials
- Thyroid cancer12 works · 5 trials
- Mantle cell lymphoma10 works · 10 trials
- Pituitary tumours5 works · 0 trials
- Cushing's syndrome4 works · 0 trials
- Barrett's oesophagus3 works · 0 trials
Institution data: ROR 04qcjsm24 (CC0-1.0)Updated 15 Nov 2026